Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Website: pfizer.com


  • Bad financial results growth rate -28.4% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (13.8%)
  • Dividend yield for the last twelve months 5.7%
  • Free cash flow yield 0.0% (LTM)
  • Share price is 14.5% higher than minimum and 52.8% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (53.7x vs
    )
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: PFE  postmarket  28.98  (+0.2%)
Share price, USD:  (+1.9%)28.92
year average price 31.47  


year start price 36.77 2023-05-19

max close price 40.28 2023-06-13

min close price 25.26 2024-04-25

current price 28.92 2024-05-17
Common stocks: 5 615 000 000

Dividend Yield:  5.7%
EV / LTM EBITDA: 53.7x
EV / EBITDA annualized: 8.8x
Last revenue growth (y/y):  -18.6%
Last growth of EBITDA (y/y):  -38.2%
Historical revenue growth:  16.4%
Historical growth of EBITDA:  11.2%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 162 386
Net Debt ($m): 13 353
EV (Enterprise Value): 175 739
EBITDA LTM ($m): 3 273
EV / LTM EBITDA: 53.7x
Price to Book: 1.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2024-05-16seekingalpha.com

Pfizer: Potential Double-Digit Upside Combined With High Dividend Yield

2024-05-15Seeking Alpha

Pfizer: Best Trading Momentum Since 2021 And 6% Yield

2024-05-13Invezz

Pfizer's next move: Can it break above $30?

2024-05-13The Motley Fool

Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock

2024-05-10Barrons

A Struggling Pfizer Looks for Help From a Wall Streeter

2024-05-09The Motley Fool

2 No-Brainer Dividend Stocks to Buy in May

2024-05-09The Motley Fool

This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream

2024-05-08New York Post

Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer

2024-05-08Seeking Alpha

Pfizer: A 6% Yield And At 10-Year Lows

2024-05-07Reuters

Pfizer reports patient death in Duchenne gene therapy study
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data